These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30204326)

  • 1. Evaluation of diabetic marker Hba1c and anemia in the context of kidney disease.
    Sivaraman P; Patel N; Weissman A
    MLO Med Lab Obs; 2016 Nov; 48(11):24, 26. PubMed ID: 30204326
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamylated hemoglobin remains a critical issue in HbA1c measurements.
    Szymezak J; Lavalard E; Martin M; Leroy N; Gillery P
    Clin Chem Lab Med; 2009; 47(5):612-3. PubMed ID: 19397488
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme immunoassay of hemoglobin A1c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia.
    Engbaek F; Christensen SE; Jespersen B
    Clin Chem; 1989 Jan; 35(1):93-7. PubMed ID: 2463121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
    Twomey PJ; Viljoen A; Reynolds TM; Wierzbicki AS
    Diabetes Care; 2004 Oct; 27(10):2569-70. PubMed ID: 15451948
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
    Gan T; Liao B; Xu G
    J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylated or carbamylated hemoglobin in uremia?
    Tesio F; Cecchin E; De Marchi S; Quaia P
    N Engl J Med; 1982 Apr; 306(17):1053-4. PubMed ID: 7063001
    [No Abstract]   [Full Text] [Related]  

  • 10. Does carbamylated hemoglobin still affect the analysis of HbA(1c) in uremic and hyperglycemic patients?
    Meijs MF; Dijkhorst-Oei LT; van Loo R; Bosma RJ; Weykamp CW; Wielders JP
    Clin Chem Lab Med; 2008; 46(12):1791-2. PubMed ID: 19055458
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbamylated hemoglobin interference in glycohemoglobin assays.
    Weykamp CW; Miedema K; de Haan T; Doelman CJ
    Clin Chem; 1999 Mar; 45(3):438-40. PubMed ID: 10053058
    [No Abstract]   [Full Text] [Related]  

  • 12. Anemia in diabetes: Experience of a single treatment center in Kuwait.
    Alsayegh F; Waheedi M; Bayoud T; Al Hubail A; Al-Refaei F; Sharma P
    Prim Care Diabetes; 2017 Aug; 11(4):383-388. PubMed ID: 28473191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study.
    Yan Y; Kondo N; Oniki K; Watanabe H; Imafuku T; Sakamoto Y; Shigaki T; Maruyama A; Nakazawa H; Kaneko T; Morita A; Yoshida A; Maeda H; Maruyama T; Jinnouchi H; Saruwatari J
    J Diabetes Res; 2022; 2022():6934188. PubMed ID: 35103243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insights on glycated albumin].
    Hay-Lombardie A; Kamel S; Bigot-Corbel E
    Ann Biol Clin (Paris); 2019 Aug; 77(4):407-414. PubMed ID: 31418702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA
    Desmons A; Jaisson S; Leroy N; Gillery P; Guillard E
    Biochem Med (Zagreb); 2017 Jun; 27(2):378-386. PubMed ID: 28694727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the Role of HbA1c in Diabetic Hemodialysis Patients?
    Coelho S
    Semin Dial; 2016; 29(1):19-23. PubMed ID: 26138753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of glycosylated hemoglobin (HbA1) in renal failure.
    Kumar S; Mangal BD; Alam SM; Srivastava DK; Vajpeyi GN; Garg SK
    J Assoc Physicians India; 1983 Feb; 31(2):69-71. PubMed ID: 6885711
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
    Snit M; Dwornicki M; Zukowska-Szczechowska E; Grzeszczak W
    Diabetes Care; 2007 Jan; 30(1):189; author reply 189-90. PubMed ID: 17192370
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,5-Anhydroglucitol and glycated albumin in glycemia.
    Koga M
    Adv Clin Chem; 2014; 64():269-301. PubMed ID: 24938022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
    Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H
    Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.